Literature DB >> 16876804

Serum endogenous secretory RAGE levels are inversely associated with carotid IMT in type 2 diabetic patients.

Naoto Katakami, Munehide Matsuhisa, Hideaki Kaneto, Yoshimitsu Yamasaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16876804     DOI： 10.1016/j.atherosclerosis.2006.06.019

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  12 in total

1.  Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS).

Authors:  Barry I Hudson; Yeseon Park Moon; Anastasia Z Kalea; Minesh Khatri; Chensy Marquez; Ann Marie Schmidt; Myunghee C Paik; Mitsuhiro Yoshita; Ralph L Sacco; Charles DeCarli; Clinton B Wright; Mitchell S V Elkind
Journal:  Atherosclerosis       Date:  2011-01-21       Impact factor: 5.162

2.  Relationship between serum levels of endogenous secretory RAGE and blood pressure in male nondiabetic patients with obstructive sleep apnea.

Authors:  W Cai; J-F Sun; Y Liu; J-X Xu; J-R Xiao; X-M Duan; J-Y Liu; W Zhang
Journal:  J Hum Hypertens       Date:  2015-05-21       Impact factor: 3.012

Review 3.  Advanced glycation endproducts: from precursors to RAGE: round and round we go.

Authors:  Ravichandran Ramasamy; Shi Fang Yan; Ann Marie Schmidt
Journal:  Amino Acids       Date:  2010-10-19       Impact factor: 3.520

Review 4.  Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.

Authors:  Shi Fang Yan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  J Mol Med (Berl)       Date:  2009-02-03       Impact factor: 4.599

5.  Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases.

Authors:  Hidenori Koyama; Hiroshi Yamamoto; Yoshiki Nishizawa
Journal:  Biomark Insights       Date:  2007-09-17

Review 6.  RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases.

Authors:  Hidenori Koyama; Hiroshi Yamamoto; Yoshiki Nishizawa
Journal:  Mol Med       Date:  2007 Nov-Dec       Impact factor: 6.354

Review 7.  Soluble forms of RAGE in internal medicine.

Authors:  Natale Vazzana; Francesca Santilli; Chiara Cuccurullo; Giovanni Davì
Journal:  Intern Emerg Med       Date:  2009-09-02       Impact factor: 3.397

Review 8.  AGE-RAGE Stress and Coronary Artery Disease.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2021-01-21

9.  Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.

Authors:  Helen M Colhoun; D John Betteridge; Paul Durrington; Graham Hitman; Andrew Neil; Shona Livingstone; Valentine Charlton-Menys; Weihang Bao; David A Demicco; Gregory M Preston; Harshal Deshmukh; Kathryn Tan; John H Fuller
Journal:  Diabetes       Date:  2011-07-19       Impact factor: 9.461

10.  Levels of Soluble Receptor for Advanced Glycation End Products in Acute Ischemic Stroke without a Source of Cardioembolism.

Authors:  Hyun-Young Park; Kyeong Ho Yun; Do-Sim Park
Journal:  J Clin Neurol       Date:  2009-09-30       Impact factor: 3.077
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.